JP2009502770A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502770A5 JP2009502770A5 JP2008522089A JP2008522089A JP2009502770A5 JP 2009502770 A5 JP2009502770 A5 JP 2009502770A5 JP 2008522089 A JP2008522089 A JP 2008522089A JP 2008522089 A JP2008522089 A JP 2008522089A JP 2009502770 A5 JP2009502770 A5 JP 2009502770A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydroxy
- pharmaceutically acceptable
- alkyl
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 3
- 201000006549 dyspepsia Diseases 0.000 claims 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010030216 Oesophagitis Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000010643 digestive system disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000006881 esophagitis Diseases 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 230000030135 gastric motility Effects 0.000 claims 1
- 208000029493 gastroesophageal disease Diseases 0.000 claims 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 1
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 230000008673 vomiting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70169105P | 2005-07-22 | 2005-07-22 | |
| US60/701,691 | 2005-07-22 | ||
| PCT/IB2006/002120 WO2007010390A1 (en) | 2005-07-22 | 2006-07-14 | Indazolecarboxamide derivatives as 5ht4 receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009502770A JP2009502770A (ja) | 2009-01-29 |
| JP2009502770A5 true JP2009502770A5 (https=) | 2009-04-16 |
| JP5075818B2 JP5075818B2 (ja) | 2012-11-21 |
Family
ID=36942190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522089A Expired - Fee Related JP5075818B2 (ja) | 2005-07-22 | 2006-07-14 | ５ｈｔ４受容体アゴニストとしてのインダゾールカルボキサミド誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7906532B2 (https=) |
| EP (1) | EP1910340B1 (https=) |
| JP (1) | JP5075818B2 (https=) |
| AT (1) | ATE449092T1 (https=) |
| CA (1) | CA2615611C (https=) |
| DE (1) | DE602006010563D1 (https=) |
| ES (1) | ES2333545T3 (https=) |
| WO (1) | WO2007010390A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| JP2009539806A (ja) * | 2006-06-08 | 2009-11-19 | シュペーデル・エクスペリメンタ・アーゲー | ２，５−二置換ピペリジン |
| WO2009106599A2 (en) * | 2008-02-29 | 2009-09-03 | Novartis Ag | Substituted piperidines as therapeutic compounds |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011030349A1 (en) | 2009-09-14 | 2011-03-17 | Suven Life Sciences Limited | L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| KR20140041519A (ko) * | 2011-06-07 | 2014-04-04 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 인다졸-유도체 및 피롤로피리딘-유도체 및 그의 약제학적 용도 |
| AP3307A (en) | 2011-09-19 | 2015-06-30 | Suven Life Sciences Ltd | Heteroaryl compounds as 5-HT4 receptor ligands |
| ES2674993T3 (es) | 2013-03-20 | 2018-07-05 | Suven Life Sciences Limited | Derivados de 5-amino-quinolina-8-carboxamida como agonistas del receptor 5-HT4 |
| KR101824154B1 (ko) | 2013-12-16 | 2018-03-14 | 수벤 라이프 사이언시스 리미티드 | 5-ｈｔ４ 수용체 작용제로서 인다졸 화합물 |
| EP3265459B1 (en) | 2015-02-13 | 2019-05-15 | Suven Life Sciences Limited | Amide compounds as 5-ht4 receptor agonists |
| JP6900028B2 (ja) * | 2017-03-29 | 2021-07-07 | 国立大学法人帯広畜産大学 | パーキンソン病に併発した認知障害の治療剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117438A (en) | 1995-03-16 | 2001-12-23 | Lilly Co Eli | Indazolecarboxamides, their preparation and pharmaceutical compositions containing them |
| EP0829474B1 (en) * | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Indazole derivatives having monocyclic amino group |
| US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| JP4740152B2 (ja) * | 2003-12-23 | 2011-08-03 | セロドス アクスイェ セルスカブ | 末梢性５−ｈｔ受容体の修飾因子 |
-
2006
- 2006-07-14 US US11/995,179 patent/US7906532B2/en not_active Expired - Fee Related
- 2006-07-14 DE DE602006010563T patent/DE602006010563D1/de active Active
- 2006-07-14 CA CA2615611A patent/CA2615611C/en not_active Expired - Fee Related
- 2006-07-14 EP EP06779924A patent/EP1910340B1/en not_active Not-in-force
- 2006-07-14 WO PCT/IB2006/002120 patent/WO2007010390A1/en not_active Ceased
- 2006-07-14 AT AT06779924T patent/ATE449092T1/de not_active IP Right Cessation
- 2006-07-14 JP JP2008522089A patent/JP5075818B2/ja not_active Expired - Fee Related
- 2006-07-14 ES ES06779924T patent/ES2333545T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2598536A1 (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
| CA2569654A1 (en) | Benzimidazolone carboxylic acid derivatives | |
| JP2009502770A5 (https=) | ||
| CA2537127A1 (en) | Benzimidazolone compounds having 5-ht4 receptor agonistic activity | |
| JP2010530431A5 (https=) | ||
| JP2004528334A5 (https=) | ||
| CZ20031941A3 (cs) | Substituované triazol diaminové deriváty jako inhibitory kináz | |
| JP2006514011A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| JP2006504658A5 (https=) | ||
| CA2463284A1 (en) | Pyrimidine compounds and pharmaceutical compositions containing the compounds | |
| JP2007246474A5 (https=) | ||
| JP2006501202A (ja) | Ｍｃｈ調節作用を有するジアリール置換環状尿素誘導体 | |
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| JP2007520440A5 (https=) | ||
| JP2005506298A5 (https=) | ||
| JP2004043453A (ja) | （ｓ）−４−アミノ−５−クロロ−２−メトキシ−ｎ−［１−［１−（２−テトラヒドロフリルカルボニル）−４−ピペリジニルメチル］−４−ピペリジニル］ベンズアミド、その製造方法、それを含有する医薬組成物及び該化合物の中間体 | |
| RU2001120723A (ru) | Производные имидазола и их медицинское применение | |
| CA2615611A1 (en) | Indazole derivatives | |
| JP2007530561A5 (https=) | ||
| JP2005526024A5 (https=) | ||
| JP2005501870A5 (https=) | ||
| CA2598516A1 (en) | Benzisoxazole derivatives | |
| JP2010534670A5 (https=) | ||
| JPWO2009104729A1 (ja) | アミド誘導体及びそれを含有する医薬組成物 |